These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 9453932

  • 21. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
    Geronimi-Ferret D, Lesay M, Barges-Bertocchio MH, Cornet-Bonnefont M, Robert H.
    Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
    [Abstract] [Full Text] [Related]

  • 22. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1330-6. PubMed ID: 17618026
    [Abstract] [Full Text] [Related]

  • 23. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M, Knopf U, Henn FA, Thome J.
    Pharmacopsychiatry; 2004 Jan 15; 37(1):26-31. PubMed ID: 14750045
    [Abstract] [Full Text] [Related]

  • 24. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.
    Encephale; 2008 Oct 15; 34(5):526-33. PubMed ID: 19068343
    [Abstract] [Full Text] [Related]

  • 25. Clinical use of clozapine in a major urban setting: one year experience.
    Chow EW, Collins EJ, Nuttall SE, Bassett AS.
    J Psychiatry Neurosci; 1995 Mar 15; 20(2):133-40. PubMed ID: 7703222
    [Abstract] [Full Text] [Related]

  • 26. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C, Schulz E, Remschmidt H.
    J Psychiatr Res; 1998 Mar 15; 32(5):325-33. PubMed ID: 9789212
    [Abstract] [Full Text] [Related]

  • 27. [Schizophrenia, affective symptoms and clozapine].
    Meynard JA, Bernadet R, Sanchez MF, Morel P.
    Encephale; 1995 Jun 15; 21 Spec No 3():41-7. PubMed ID: 7628341
    [Abstract] [Full Text] [Related]

  • 28. [Weight gain and clozapine].
    Jalenques I, Tauveron I, Albuisson E, Audy V.
    Encephale; 1996 Oct 15; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract] [Full Text] [Related]

  • 29. [Clozapine and treatment of negative symptoms].
    Lançon C, Farisse J, Llorca PM.
    Encephale; 1997 Sep 15; 23 Spec No 4():7-11. PubMed ID: 9417403
    [Abstract] [Full Text] [Related]

  • 30. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
    Fleischhaker C, Schulz E, Remschmidt H.
    Z Kinder Jugendpsychiatr Psychother; 1998 Dec 15; 26(4):235-43. PubMed ID: 9880833
    [Abstract] [Full Text] [Related]

  • 31. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P, Jolivel C, Bret MC, Veylit S, Martin C, Garcia P.
    Encephale; 1998 Dec 15; 24(4):365-77. PubMed ID: 9809242
    [Abstract] [Full Text] [Related]

  • 32. Seizure activity in combined clozapine and ECT: a retrospective view.
    Cardwell BA, Nakai B.
    Convuls Ther; 1995 Jun 15; 11(2):110-3. PubMed ID: 7552049
    [Abstract] [Full Text] [Related]

  • 33. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H, Chengappa KN, Kambhampati RK, Mahdavi N, Ganguli R.
    J Clin Psychiatry; 1992 Jul 15; 53(7):248-51. PubMed ID: 1353492
    [Abstract] [Full Text] [Related]

  • 34. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
    Banov MD, Zarate CA, Tohen M, Scialabba D, Wines JD, Kolbrener M, Kim JW, Cole JO.
    J Clin Psychiatry; 1994 Jul 15; 55(7):295-300. PubMed ID: 8071290
    [Abstract] [Full Text] [Related]

  • 35. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec 15; (31):21-30. PubMed ID: 8968652
    [No Abstract] [Full Text] [Related]

  • 36. Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients.
    Löffler S, Löffler-Ensgraber M, Fehsel K, Klimke A.
    Int Clin Psychopharmacol; 2010 Mar 15; 25(2):101-6. PubMed ID: 20101184
    [Abstract] [Full Text] [Related]

  • 37. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH.
    Mov Disord; 1994 May 15; 9(3):321-4. PubMed ID: 7913739
    [Abstract] [Full Text] [Related]

  • 38. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors.
    Beherec L, Lambrey S, Quilici G, Rosier A, Falissard B, Guillin O.
    J Clin Psychopharmacol; 2011 Jun 15; 31(3):341-4. PubMed ID: 21508854
    [Abstract] [Full Text] [Related]

  • 39. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
    Klimke A, Klieser E.
    Fortschr Neurol Psychiatr; 1995 May 15; 63(5):173-93. PubMed ID: 7782019
    [Abstract] [Full Text] [Related]

  • 40. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O, Weiner RD, McEvoy JP.
    Biol Psychiatry; 1997 Jul 15; 42(2):132-7. PubMed ID: 9209730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.